+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Osteobiologics Market by Allografts, Bone Morphogenetic Protein, Synthetic Grafts, Demineralized Bone Matrix, Ceramic Grafts, Cell Based Grafts - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968632
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The osteobiologics market is at a pivotal moment, shaped by rapid advances in regenerative medicine and the increasing complexity of bone disorder treatments globally. As decision-makers seek reliable data for strategic planning, an in-depth understanding of market dynamics, segmentation, and regulatory shifts is essential for effective leadership.

Market Snapshot: Osteobiologics Sector Performance

The Osteobiologics Market grew from USD 1.36 billion in 2024 to USD 1.44 billion in 2025. It is expected to continue growing at a CAGR of 5.50%, reaching USD 1.88 billion by 2030. This trajectory is fueled by rising demand for bone graft substitutes and regenerative therapies, particularly as healthcare infrastructure strengthens and populations age. Innovation across biomaterials and clinical techniques further drives adoption, while evolving regulatory frameworks and reimbursement models influence operational and pricing strategies. The sector’s ongoing expansion highlights the critical need for targeted, evidence-based market intelligence.

Scope & Segmentation

Clear segmentation is crucial for targeted product development and adaptation to heterogeneous clinical demands. The osteobiologics market report provides a structured analysis by product, region, and technology:

  • Allograft Types: Freeze dried, fresh frozen.
  • Bone Morphogenetic Proteins: Bmp-2, Bmp-7.
  • Synthetic Grafts: Composites, hydroxyapatite, tricalcium phosphate.
  • Demineralized Bone Matrix Forms: Fibers, gel, powder, putty.
  • Ceramic Graft Options: Bioactive glass, bioceramics.
  • Cell-Based Grafts: Allogenic, autologous.
  • Geographic Regions: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East and Africa (such as United Kingdom, Germany, France, UAE, South Africa, and others), Asia-Pacific (including China, India, Japan, Australia, South Korea, and select Southeast Asian markets).
  • Key Players Analyzed: Medtronic plc, Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings, Baxter International, Globus Medical, NuVasive, RTI Surgical, Orthofix Medical, Exactech.

Emphasizing these segments helps stakeholders match products and strategies to evolving healthcare requirements and demographic trends across global markets.

Key Takeaways for Senior Decision-Makers

  • Innovation in tissue engineering—such as the integration of 3D-printed scaffolds with growth factors—is reshaping clinical options for complex bone repair and spinal procedures.
  • Streamlined regulatory pathways are supporting faster market entry for combination products that blend biologics and devices, changing compliance and commercial timelines.
  • Value-based reimbursement models are prompting manufacturers to align product development with measurable patient outcomes and hospital priorities.
  • Synergistic collaborations among academic institutions, biotech startups, and established medtech firms accelerate R&D and facilitate technology transfer, promoting a more dynamic innovation ecosystem.
  • Sustainability and supply chain resilience are emerging as key differentiators, with leaders prioritizing eco-friendly production, nearshoring, and risk management strategies.
  • Regional variations in adoption rates underscore the importance of customizing offerings to local infrastructure and clinical preferences, particularly in emerging economies.

Tariff Impact and Strategic Responses

The scheduled introduction of new U.S. import tariffs in 2025 presents cost pressures for osteobiologics manufacturers. This development is prompting a shift towards domestic sourcing and greater investment in local production. Strategic partnerships with regional suppliers are mitigating tariff-linked risks and supporting continuity in the value chain. Forward-thinking procurement teams are negotiating longer-term contracts, while investments in technology transfer ensure commercial adaptability amid regulatory and fiscal uncertainty.

Methodology & Data Sources

This report applies a multi-tiered research framework, utilizing interviews with surgeons, procurement executives, and regulatory experts for primary insights. Secondary data from industry publications, peer-reviewed studies, and financial disclosures further inform segmentation and competitor analysis. Data triangulation and validation sessions with domain authorities enhance the accuracy and reliability of findings.

Why This Report Matters

  • Enables senior executives to anticipate and adapt to clinical, operational, and regulatory changes impacting the osteobiologics market.
  • Equips commercial leaders with actionable insights to refine product portfolios, optimize supply chains, and navigate tariff-driven volatility.
  • Supports long-term growth planning and investment decisions by clarifying regional nuances and technology adoption trajectories.

Conclusion

The osteobiologics market is undergoing significant transformation across technologies, regulatory standards, and regional adoption. Decision-makers equipped with robust, data-driven intelligence are best positioned to align strategy, mitigate risk, and foster innovation that meets evolving clinical needs.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Osteobiologics Market, by Allografts
8.1. Introduction
8.2. Freeze Dried
8.3. Fresh Frozen
9. Osteobiologics Market, by Bone Morphogenetic Protein
9.1. Introduction
9.2. Bmp-2
9.3. Bmp-7
10. Osteobiologics Market, by Synthetic Grafts
10.1. Introduction
10.2. Composites
10.3. Hydroxyapatite
10.4. Tricalcium Phosphate
11. Osteobiologics Market, by Demineralized Bone Matrix
11.1. Introduction
11.2. Fibers
11.3. Gel
11.4. Powder
11.5. Putty
12. Osteobiologics Market, by Ceramic Grafts
12.1. Introduction
12.2. Bioactive Glass
12.3. Bioceramics
13. Osteobiologics Market, by Cell Based Grafts
13.1. Introduction
13.2. Allogenic
13.3. Autologous
14. Americas Osteobiologics Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Osteobiologics Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Osteobiologics Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Medtronic plc
17.3.2. Johnson & Johnson
17.3.3. Stryker Corporation
17.3.4. Zimmer Biomet Holdings, Inc.
17.3.5. Baxter International Inc.
17.3.6. Globus Medical, Inc.
17.3.7. NuVasive, Inc.
17.3.8. RTI Surgical, Inc.
17.3.9. Orthofix Medical Inc.
17.3.10. Exactech, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. OSTEOBIOLOGICS MARKET MULTI-CURRENCY
FIGURE 2. OSTEOBIOLOGICS MARKET MULTI-LANGUAGE
FIGURE 3. OSTEOBIOLOGICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL OSTEOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2024 VS 2030 (%)
FIGURE 14. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. OSTEOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. OSTEOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. OSTEOBIOLOGICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OSTEOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY FREEZE DRIED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY FRESH FROZEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BMP-2, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BMP-7, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY COMPOSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY HYDROXYAPATITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY FIBERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PUTTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BIOACTIVE GLASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BIOCERAMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. CANADA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 42. CANADA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 43. CANADA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 44. CANADA OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 45. CANADA OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 46. CANADA OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 47. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 48. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 49. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 50. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 51. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 52. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 73. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 74. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 75. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 76. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 78. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 79. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 80. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 81. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 82. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 83. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 84. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 85. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 86. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 87. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 88. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 89. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 90. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 91. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 92. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 93. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 94. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 96. ITALY OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 97. ITALY OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 98. ITALY OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 99. ITALY OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 100. ITALY OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 101. ITALY OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 102. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 103. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 104. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 105. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 106. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 107. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 108. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 109. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 110. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 111. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 112. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 114. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 115. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 116. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 120. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 126. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 127. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 128. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 129. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 130. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 131. DENMARK OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 138. QATAR OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 139. QATAR OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 140. QATAR OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 141. QATAR OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 142. QATAR OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 143. QATAR OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 144. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 145. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 146. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 147. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 148. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 149. FINLAND OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 150. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 151. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 152. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 153. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 154. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 156. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 157. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 158. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 159. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 162. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 163. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 164. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 165. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 166. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 167. EGYPT OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 168. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 169. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 170. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 171. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 172. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 173. TURKEY OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 174. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 175. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 176. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 177. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 180. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 181. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 182. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 183. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 184. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 185. NORWAY OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 186. POLAND OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 187. POLAND OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 188. POLAND OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 189. POLAND OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 190. POLAND OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 191. POLAND OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 192. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 193. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 194. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 205. CHINA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 206. CHINA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 207. CHINA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 208. CHINA OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 209. CHINA OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 210. CHINA OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 211. INDIA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 212. INDIA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 213. INDIA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 214. INDIA OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 215. INDIA OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 216. INDIA OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 217. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 218. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 219. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 220. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 221. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 222. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 229. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 230. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 231. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 241. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 242. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 243. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 244. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 245. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 246. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 247. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 248. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 249. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 259. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 260. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 261. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 265. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 266. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 267. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 268. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEIN, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY CERAMIC GRAFTS, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN OSTEOBIOLOGICS MARKET SIZE, BY CELL BASED GRAFTS, 2018-2030 (USD MILLION)
TABLE 277. OSTEOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 278. OSTEOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Osteobiologics market report include:
  • Medtronic plc
  • Johnson & Johnson
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Baxter International Inc.
  • Globus Medical, Inc.
  • NuVasive, Inc.
  • RTI Surgical, Inc.
  • Orthofix Medical Inc.
  • Exactech, Inc.

Table Information